513 related articles for article (PubMed ID: 19651619)
1. GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells.
Tran DQ; Andersson J; Wang R; Ramsey H; Unutmaz D; Shevach EM
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13445-50. PubMed ID: 19651619
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the expression of GARP/latent TGF-β1 complexes on mouse T cells and their role in regulatory T cell and Th17 differentiation.
Edwards JP; Fujii H; Zhou AX; Creemers J; Unutmaz D; Shevach EM
J Immunol; 2013 Jun; 190(11):5506-15. PubMed ID: 23645881
[TBL] [Abstract][Full Text] [Related]
3. GARP-TGF-β complexes negatively regulate regulatory T cell development and maintenance of peripheral CD4+ T cells in vivo.
Zhou AX; Kozhaya L; Fujii H; Unutmaz D
J Immunol; 2013 May; 190(10):5057-64. PubMed ID: 23576681
[TBL] [Abstract][Full Text] [Related]
4. The Tregs' world according to GARP.
Battaglia M; Roncarolo MG
Eur J Immunol; 2009 Dec; 39(12):3296-300. PubMed ID: 19904770
[TBL] [Abstract][Full Text] [Related]
5. Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg.
Stockis J; Colau D; Coulie PG; Lucas S
Eur J Immunol; 2009 Dec; 39(12):3315-22. PubMed ID: 19750484
[TBL] [Abstract][Full Text] [Related]
6. Garp as a therapeutic target for modulation of T regulatory cell function.
Shevach EM
Expert Opin Ther Targets; 2017 Feb; 21(2):191-200. PubMed ID: 28001437
[TBL] [Abstract][Full Text] [Related]
7. GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-β releasing.
Sun L; Jin H; Li H
Oncotarget; 2016 Jul; 7(27):42826-42836. PubMed ID: 27095576
[TBL] [Abstract][Full Text] [Related]
8. Release of active TGF-β1 from the latent TGF-β1/GARP complex on T regulatory cells is mediated by integrin β8.
Edwards JP; Thornton AM; Shevach EM
J Immunol; 2014 Sep; 193(6):2843-9. PubMed ID: 25127859
[TBL] [Abstract][Full Text] [Related]
9. The GARP/Latent TGF-β1 complex on Treg cells modulates the induction of peripherally derived Treg cells during oral tolerance.
Edwards JP; Hand TW; Morais da Fonseca D; Glass DD; Belkaid Y; Shevach EM
Eur J Immunol; 2016 Jun; 46(6):1480-9. PubMed ID: 27062243
[TBL] [Abstract][Full Text] [Related]
10. TGF-β induces surface LAP expression on murine CD4 T cells independent of Foxp3 induction.
Oida T; Weiner HL
PLoS One; 2010 Nov; 5(11):e15523. PubMed ID: 21124798
[TBL] [Abstract][Full Text] [Related]
11. Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells.
Wang R; Kozhaya L; Mercer F; Khaitan A; Fujii H; Unutmaz D
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13439-44. PubMed ID: 19666573
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor β1 (TGF-β1) Production in Human Regulatory T Cells.
Huygens C; Liénart S; Dedobbeleer O; Stockis J; Gauthy E; Coulie PG; Lucas S
J Biol Chem; 2015 Aug; 290(33):20105-16. PubMed ID: 26126825
[TBL] [Abstract][Full Text] [Related]
13. Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8.
Stockis J; Liénart S; Colau D; Collignon A; Nishimura SL; Sheppard D; Coulie PG; Lucas S
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10161-E10168. PubMed ID: 29109269
[TBL] [Abstract][Full Text] [Related]
14. Heme oxygenase-1 restores impaired GARPCD4⁺CD25⁺ regulatory T cells from patients with acute coronary syndrome by upregulating LAP and GARP expression on activated T lymphocytes.
Liu Y; Zhao X; Zhong Y; Meng K; Yu K; Shi H; Wu B; Tony H; Zhu J; Zhu R; Peng Y; Mao Y; Cheng P; Mao X; Zeng Q
Cell Physiol Biochem; 2015; 35(2):553-70. PubMed ID: 25612606
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in FoxP3- and GARP/LAP-Expressing T Regulatory Cells in an HLA Class II Transgenic Murine Model of Necrotizing Soft Tissue Infections by Group A Streptococcus.
Nookala S; Mukundan S; Fife A; Alagarsamy J; Kotb M
Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30224551
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF-β1/GARP Complex.
Li Y; Kim BG; Qian S; Letterio JJ; Fung JJ; Lu L; Lin F
J Immunol; 2015 Sep; 195(6):2648-56. PubMed ID: 26246140
[TBL] [Abstract][Full Text] [Related]
17. Anti-GARP Antibodies Inhibit Release of TGF-β by Regulatory T Cells via Different Modes of Action, but Do Not Influence Their Function In Vitro.
Igney FH; Ebenhoch R; Schiele F; Nar H
Immunohorizons; 2023 Mar; 7(3):200-212. PubMed ID: 36928178
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells.
Liénart S; Merceron R; Vanderaa C; Lambert F; Colau D; Stockis J; van der Woning B; De Haard H; Saunders M; Coulie PG; Savvides SN; Lucas S
Science; 2018 Nov; 362(6417):952-956. PubMed ID: 30361387
[TBL] [Abstract][Full Text] [Related]
19. Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP.
Elkord E; Abd Al Samid M; Chaudhary B
Oncotarget; 2015 Aug; 6(24):20026-36. PubMed ID: 26343373
[TBL] [Abstract][Full Text] [Related]
20. FOXP3: required but not sufficient. the role of GARP (LRRC32) as a safeguard of the regulatory phenotype.
Probst-Kepper M; Balling R; Buer J
Curr Mol Med; 2010 Aug; 10(6):533-9. PubMed ID: 20642442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
